Impact of Propionic Acid on Regulatory T Cell Function in Healthy Adults ( Pro-Health)

NAActive, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

February 28, 2024

Study Completion Date

May 30, 2025

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Sodium propionate

The patients will be randomized to PA or placebo intervention (2:1 randomization). After the intervention of 28 days, we conduct an open-label study phase, where all patients are offered a dietary supplement of PA for overall 12 weeks (8 additional weeks for the intervention group and 12 weeks for the placebo group). By doing so we are giving every patient the opportunity to take PA and benefit from the possible positive impact on immunsystem and intestinal barrier function.

OTHER

Placebo

"The patients will be randomized to PA or placebo intervention (2:1 randomization).~After the intervention of 28 days, we conduct an open-label study phase, where all patients are offered a dietary supplement of PA for overall 12 weeks (8 additional weeks for the intervention group and 12 weeks for the placebo group).~By doing so we are giving every patient the opportunity to take PA and benefit from the possible positive impact on immunsystem and intestinal barrier function."

Trial Locations (1)

13353

Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité-Universitätsmedizin Berlin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT06198374 - Impact of Propionic Acid on Regulatory T Cell Function in Healthy Adults ( Pro-Health) | Biotech Hunter | Biotech Hunter